Mesenchymal stem cell-derived exosomes: A novel potential therapeutic avenue for cardiac regeneration

被引:31
作者
Safari, S. [1 ,2 ]
Malekvandfard, F. [3 ]
Babashah, S. [4 ]
Alizadehasl, A. [5 ]
Sadeghizadeh, M. [4 ]
Motavaf, M. [2 ,4 ]
机构
[1] Iran Univ Med Sci, Rasoul Akram Med Ctr, Dept Anesthesiol, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Mycobacteriol Res Ctr, Tehran, Iran
[3] Islamic Azad Univ, Sci & Res Branch, Dept Biol, Tehran, Iran
[4] Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, POB 14115-154, Tehran, Iran
[5] Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran
关键词
Coronary artery diseases; cardiac regeneration; mesenchymal stem cells; exosome; STROMAL CELLS; NEUROVASCULAR PLASTICITY; MYOCARDIAL-INFARCTION; FUNCTIONAL RECOVERY; OXIDATIVE STRESS; EMERGING ROLE; REPAIR; TRANSPLANTATION; REPERFUSION; MECHANISMS;
D O I
10.14715/cmb/2016.62.7.12
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Coronary artery diseases (CADs) represent a significant cause of death worldwide. During recent decades the rate of cardiovascular mortality has been declined as a result of modern medicine and surgery. However, despite the fact that cardiac cells, including cardiomyocytes (CMCs), vascular smooth muscle cells (VSMC) and vascular endothelial cells (VEC), can be regenerated by cardiac adult stem cell, the regenerative capacity of these cells are limited and inadequate to functionally regenerate heart damaged tissue. Thus, growth reserve of the heart fails to restore the structural integrity of the myocardium after infarction and healing is associated with scar formation. An explanation for this is that cardiac reside stem cells are present throughout the infarction site but die rapidly by apoptosis. Furthermore, microenvironment surrounding the damage site is not promising for the cells survival and renewal. Hence, recent advances in the stem cell therapy have emerged as an attractive approach to replace the lost cells. In this context, mesenchymal stem cells (MSCs) has considered as one of the most promising candidates for regeneration of cardiac cells, lost upon injury. The regenerative capacity of MSCs has primarily been centered on the hypothesis that these cells would engraft, differentiate and replace damaged cardiac cells. However, experimental and clinical observations so far have failed to establish if this differentiated is considerably relevant to MSCs cardiac regenerative properties. Recent reports have suggested that these therapeutic properties, at least in part, are mediated by paracrine factors released from MSCs. This review provides a concise summary of current evidences supporting the paracrine hypothesis of MSCs. In particular, the scope of this review focuses on the role of MSC-derived exosome (MSC-EXs) as a therapeutic modality for the treatment of CADs, particularly ischemic myocardial dysfunctions.
引用
收藏
页码:66 / 73
页数:8
相关论文
共 65 条
[1]   Elevated expression of MeCP2 in cardiac and skeletal tissues is detrimental for normal development [J].
Alvarez-Saavedra, Matias ;
Carrasco, Loreto ;
Sura-Trueba, Sylvia ;
Aiello, Vera Demarchi ;
Walz, Katherina ;
Xavier Neto, Jose ;
Young, Juan I. .
HUMAN MOLECULAR GENETICS, 2010, 19 (11) :2177-2190
[2]  
Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
[3]   Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury [J].
Arslan, Fatih ;
Lai, Ruenn Chai ;
Smeets, Mirjam B. ;
Akeroyd, Lars ;
Choo, Andre ;
Aguor, Eissa N. E. ;
Timmers, Leo ;
van Rijen, Harold V. ;
Doevendans, Pieter A. ;
Pasterkamp, Gerard ;
Lim, Sai Kiang ;
de Kleijn, Dominique P. .
STEM CELL RESEARCH, 2013, 10 (03) :301-312
[4]   Resident cardiac progenitor cells: At the heart of regeneration [J].
Bollini, Sveva ;
Smart, Nicola ;
Riley, Paul R. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 50 (02) :296-303
[5]  
Boyle AJ, 2010, METHODS MOL BIOL, V660, P65, DOI 10.1007/978-1-60761-705-1_5
[6]  
Bsargent, 2015, EXOSUMES MAJOR PHENO
[7]   Mesenchymal stem cells as trophic mediators [J].
Caplan, Arnold I. ;
Dennis, James E. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 98 (05) :1076-1084
[8]   Adult Cardiac-Resident MSC-like Stem Cells with a Proepicardial Origin [J].
Chong, James J. H. ;
Chandrakanthan, Vashe ;
Xaymardan, Munira ;
Asli, Naisana S. ;
Li, Joan ;
Ahmed, Ishtiaq ;
Heffernan, Corey ;
Menon, Mary K. ;
Scarlett, Christopher J. ;
Rashidianfar, Amirsalar ;
Biben, Christine ;
Zoellner, Hans ;
Colvin, Emily K. ;
Pimanda, John E. ;
Biankin, Andrew V. ;
Zhou, Bin ;
Pu, William T. ;
Prall, Owen W. J. ;
Harvey, Richard P. .
CELL STEM CELL, 2011, 9 (06) :527-540
[9]   Randomized, double-blind, phase I/II study of intravenous allogeneic mesenchymal stromal cells in acute myocardial infarction [J].
Chullikana, Anoop ;
Sen Majumdar, Anish ;
Gottipamula, Sanjay ;
Krishnamurthy, Sagar ;
Kumar, A. Sreenivas ;
Prakash, V. S. ;
Gupta, Pawan Kumar .
CYTOTHERAPY, 2015, 17 (03) :250-261
[10]   Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling [J].
Cohn, JN ;
Ferrari, R ;
Sharpe, N .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) :569-582